Thermo Fisher Scientific
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Thermo Fisher Scientific (TMO) Business News
Track Thermo Fisher Scientific in real time with a live news feed covering Thermo Fisher Scientific stock news, official press releases, company announcements, and an archive of historical Thermo Fisher Scientific news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
DNB Asset Management AS Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO
DNB Asset Management AS Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Citizens Business Bank
Thermo Fisher Scientific Increases Quarterly Dividend
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference
Fairbanks Capital Management Inc. Acquires 1,421 Shares of Thermo Fisher Scientific Inc. $TMO
5 Oversold Stocks to Buy Before They Rebound
Thermo Fisher Scientific Inc. $TMO Shares Bought by Bleakley Financial Group LLC
Factory Mutual Insurance Co. Increases Holdings in Thermo Fisher Scientific Inc. $TMO
Fiera Capital Corp Has $73.42 Million Holdings in Thermo Fisher Scientific Inc. $TMO
DNB Asset Management AS Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO
6:04 AM | Friday | Feb 27, 2026
DNB Asset Management AS cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 8.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 126,849 shares of the medical research company's stock after selling 12,465 shares during the quarter. DNB Asset
Read full article
DNB Asset Management AS Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO
Defense WorldDNB Asset Management AS cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 8.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 126,849 shares of the medical research company's stock after selling 12,465 shares during the quarter. DNB Asset
Read full article
DNB Asset Management AS Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO
Defense WorldDNB Asset Management AS cut its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 8.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 126,849 shares of the medical research company's stock after selling 12,465 shares during the quarter. DNB Asset
Read full article
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner
Business WireWEST HILLS, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TacroType™ Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection. For transplant recipients, finding the right tacrolimus dose as early as possible can be life-changing. If the dose is too low, the body may.
Read full article
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Citizens Business Bank
Defense WorldCitizens Business Bank raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 79.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,250 shares of the medical research company's stock after buying an
Read full article
Thermo Fisher Scientific Increases Quarterly Dividend
Business WireWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on April 15, 2026, to shareholders of record as of March 13, 2026. This reflects a 10% increase over the previous dividend payment of $0.
43. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40.
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference
Business WireWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Raymond James Institutional Investors Conference on Tuesday, March 3, 2026, at 9:15 a.m.
(ET). A live webcast of the presentation will be available in the Investors section of our website, www.thermofisher.com, with a replay accessible shortly after the presentation concludes. About Th.
Fairbanks Capital Management Inc. Acquires 1,421 Shares of Thermo Fisher Scientific Inc. $TMO
Defense WorldFairbanks Capital Management Inc. increased its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 77.8% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,248 shares of the medical research company's stock after purchasing an additional 1,421 shares during the quarter.
5 Oversold Stocks to Buy Before They Rebound
MorningstarIn this episode of The Morning Filter, co-hosts Dave Sekera and Susan Dziubinski unpack what the Supreme Court's ruling on the Trump Administration's emergency tariffs may mean for markets. They also discuss whether the AI-fueled stock market selloff has gone too far and where the opportunities may lie for investors today. They discuss if Nvidia's earnings report this week can lead to a recovery in AI-related stocks and if earnings releases from Salesforce CRM or Workday WDAY could lift their struggling stocks. Tune in to find out what to make of Walmart's WMT results, plus what Kraft Heinz's KHC breakup flip-flop and Elliot's investment in Norwegian Cruise Lines NCLH may mean for their stocks.
Read full article
Thermo Fisher Scientific Inc. $TMO Shares Bought by Bleakley Financial Group LLC
Defense WorldBleakley Financial Group LLC lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 10.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,425 shares of the medical research company's stock after acquiring an additional 1,500 shares during the
Read full article
Factory Mutual Insurance Co. Increases Holdings in Thermo Fisher Scientific Inc. $TMO
Defense WorldFactory Mutual Insurance Co. lifted its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 2.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 98,935 shares of the medical research company's stock after acquiring an additional 2,500 shares during the quarter.
Factory
Fiera Capital Corp Has $73.42 Million Holdings in Thermo Fisher Scientific Inc. $TMO
Defense WorldFiera Capital Corp lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 3.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 151,374 shares of the medical research company's stock after selling 4,798 shares during the quarter. Fiera Capital
Read full article